Heterogeneous gene expression changes in colorectal cancer cells share the WNT pathway in response to growth suppression by APHS-mediated COX-2 inhibition

Bostjan Humar1 Cancer Genetics Laboratory, Department of Biochemistry; University of Otago, Dunedin, Aotearoa New ZealandCorrespondence[email protected]

Les McNoe1 Cancer Genetics Laboratory, Department of Biochemistry; University of Otago, Dunedin, Aotearoa New Zealand

Anita Dunbier1 Cancer Genetics Laboratory, Department of Biochemistry; University of Otago, Dunedin, Aotearoa New Zealand

Rosemary Heathcott1 Cancer Genetics Laboratory, Department of Biochemistry; University of Otago, Dunedin, Aotearoa New Zealand

Antony W Braithwaite2 Children's Medical Research Institute, Wintworthbill, NSW, Australia

Anthony E Reeve1 Cancer Genetics Laboratory, Department of Biochemistry; University of Otago, Dunedin, Aotearoa New Zealand

Pages 329-337 | Published online: 06 Jun 2008

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

AltucciLLeibowitzMDOgilvieKM2007RAR and RXR modulation in cancer and metabolic diseaseNature Rev6793810
Web of Science ®Google Scholar
BoonEMKellerJJWormhoudtTA2004Sulindac targets nuclear beta-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell linesBr J Cancer90224914710233
PubMed Web of Science ®Google Scholar
BrownJRDuBoisRN2005COX-2: a molecular target for colorectal cancer preventionJ Clin Oncol2328405515837998
PubMed Web of Science ®Google Scholar
BrownWASkinnerSAVogiagisD2001Inhibition of beta-catenin translocation in rodent colorectal tumors: a novel explanation for the protective effect of nonsteroidal antiinflammatory drugs in colorectal cancerDig Dis Sci4623142111713928
PubMed Web of Science ®Google Scholar
CastelloneMDTeramotoHWilliamsBO2005Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axisScience31015041016293724
PubMed Web of Science ®Google Scholar
CioceVCastronovoVShmooklerBM1991Increased expression of the laminin receptor in human colon cancerJ Natl Cancer Inst8329361824600
PubMed Web of Science ®Google Scholar
FujinoHWestKAReganJW2002Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2J Biol Chem2772614911706038
PubMed Web of Science ®Google Scholar
GregorieffACleversH2005Wnt signaling in the intestinal epithelium: from endoderm to cancerGenes Dev198779015833914
PubMed Web of Science ®Google Scholar
HuangXGuoB2006Adenomatous polyposis coli determines sensitivity to histone deacetylase inhibitor-induced apoptosis in colon cancer cellsCancer Res6692455116982769
PubMed Web of Science ®Google Scholar
HumarBD’OrazioDAlbrechtC2001Expression of putative anticancer targets in familial adenomatous polyposis and its association with the APC mutation statusInt J Oncol1911798611713587
PubMed Web of Science ®Google Scholar
KalgutkarASCrewsBCRowlinsonSW1998Aspirin-like molecules that covalently inactivate cyclooxygenase-2Science2801268709596581
PubMed Web of Science ®Google Scholar
KapitanovicSCacevTAnticaM2006Effect of indomethacin on E-cadherin and beta-catenin expression in HT-29 colon cancer cellsExp Mol Pathol8091615963497
PubMed Web of Science ®Google Scholar
KirklandSC1985Dome formation by a human colonic adenocarcinoma cell line (HCA-7)Cancer Res45379054016751
PubMed Web of Science ®Google Scholar
KishimotoYYashimaKMorisawaT2002Effects of cyclooxygenase-2 inhibitor NS-398 on APC and c-myc expression in rat colon carcinogenesis induced by azoxymethaneJ Gastroenterol371869311931531
PubMed Web of Science ®Google Scholar
LevanonDGoldsteinREBernsteinY1998Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressorsProc Natl Acad Sci USA951159059751710
PubMed Web of Science ®Google Scholar
LiangJPanYLNingXX2006Overexpression of PrPC and its antiapoptosis function in gastric cancerTumour Biol27849116582585
PubMedGoogle Scholar
MaierTJJanssenASchmidtR2005Targeting the beta-catenin/APC pathway: a novel mechanism to explain the cyclooxygenase-2-independent anticarcinogenic effects of celecoxib in human colon carcinoma cellsFASEB J191353515946992
PubMed Web of Science ®Google Scholar
MariadasonJMBordonaroMAslamF2001Down-regulation of beta-catenin TCF signaling is linked to colonic epithelial cell differentiationCancer Res6134657111309309
PubMed Web of Science ®Google Scholar
MuncanVSansomOJTertoolenL2006Rapid loss of intestinal crypts upon conditional deletion of the Wnt/Tcf-4 target gene c-MycMol Cell Biol2684182616954380
PubMed Web of Science ®Google Scholar
NadauldLDSandovalITChidesterS2004Adenomatous polyposis coli control of retinoic acid biosynthesis is critical for zebrafish intestinal development and differentiationJ Biol Chem27951581915358764
PubMed Web of Science ®Google Scholar
RaoCVReddyBSSteeleVE2006Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethanetreated rats: effects on molecular targetsMol Cancer Ther51530816818512
PubMed Web of Science ®Google Scholar
RoyHKKarolskiWJWaliRK2005The nonsteroidal antiinflammatory drug, nabumetone, differentially inhibits beta-catenin signaling in the MIN mouse and azoxymethanetreated rat models of colon carcinogenesisCancer Lett217161915617833
PubMed Web of Science ®Google Scholar
ShaoJJungCLiuC2005Prostaglandin E2 Stimulates the beta-catenin/T cell factor-dependent transcription in colon cancerJ Biol Chem280265657215899904
PubMed Web of Science ®Google Scholar
TaniguchiHYamamotoHHirataT2005Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancersOncogene2479465216007117
PubMed Web of Science ®Google Scholar
van de WeteringMSanchoEVerweijC2002The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cellsCell1112415012408868
PubMed Web of Science ®Google Scholar
WilliamsJLNathNChenJ2003Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: implications for chemopreventionCancer Res637613814633677
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Heterogeneous gene expression changes in colorectal cancer cells share the WNT pathway in response to growth suppression by APHS-mediated COX-2 inhibition

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Heterogeneous gene expression changes in colorectal cancer cells share the WNT pathway in response to growth suppression by APHS-mediated COX-2 inhibition

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date